Skip to main content
Equibles

TWO SIGMA INVESTMENTS, LP

Position in AKBA — Akebia Therapeutics, Inc.

CIK 1179392 NEW YORK, NY
Back to AKBA Full portfolio

Position in AKBA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,777,807
+$973,864 QoQ
Shares Held
2,436,673
+87.8% QoQ
Ownership
0.879%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 170 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $775,744,366 across 48 Drug Manufacturers - Specialty & Generic names. AKBA ranks #26 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
 2,076,260 $349,932,860
2 BCRX
Biocryst Pharmaceuticals Inc
 6,775,349 $67,753,490
3 SUPN
Supernus Pharmaceuticals, Inc.
 1,184,378 $55,085,420
4 ALKS
Alkermes plc.
 1,038,311 $54,407,496
5 KNSA
Kiniksa Pharmaceuticals International, plc
 561,480 $35,906,646
6 ZTS
Zoetis Inc.
 386,428 $27,768,716
7 LQDA
Liquidia Corp
 266,829 $21,274,276
8 IRWD
Ironwood Pharmaceuticals Inc
 4,556,089 $19,181,134

All Filings in AKBA

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,777,807 2,436,673
2026-03-31 $1,803,943 1,297,801
2025-12-31 $145,896 90,619
2024-09-30 $32,799 24,848
2023-12-31 $229,894 185,399
2023-09-30 $31,305 27,461
2023-06-30 $197,834 216,213
2022-12-31 $215,964 374,289
2022-09-30 $169,806 537,361
2022-06-30 $75,382 213,549
2021-12-31 $219,613 97,174
2021-03-31 $2,120,963 626,577
2020-12-31 $1,458,360 520,843
2020-06-30 $5,288,635 389,443
2020-03-31 $150,288 19,827